Direct-to-Consumer Services Put Down Roots in U.S. Lab Testing Market

Direct-to-Consumer Services Put Down Roots in U.S. Lab Testing Market

Still framed as an open proposition in healthcare, the direct to consumer (DTC) lab testing market has already captured robust demand from U.S. consumers. Sales of DTC testing services have rapidly grown outside the traditional paradigm of physician-facilitated clinical testing. Kalorama Information’s Direct-to-Consumer Laboratory Testing Market has served as an important reference in recent articles by the New York Times, Forbes, and Becker’s Hospital Review.

Direct to Consumer Laboratory Testing in the News

Whereas media coverage has focused largely on the medical implications of lab results communicated without physician guidance, market growth has proceeded briskly for DTC lab services through their considerable strengths including their applicability to wellness and preventative care that remain broadly encouraged in U.S. healthcare and existing consumer proclivity to seek care and medical advice online. Future regulatory crackdowns on DTC lab services are also likely to meet staunch resistance much as expanded FDA oversight of lab-developed tests (LDTs) has met a defense coordinated by lobbyists and constitutional jurists. Direct to consumer lab testing services is increasingly a fixture in the U.S. healthcare landscape having already grown from roughly $15 million to over $130 million in revenue between 2010 and 2015.

Direct-to-Consumer Laboratory Testing Market provides insights into the two distinct segments of DTC testing services: routine/core lab testing and genetic testing. Key industry participants and formative market trends are also thoroughly reviewed in the report.